PCN208 COST-EFFECTIVENESS OF NIVOLUMAB FOR THE ADJUVANT...

PCN208 COST-EFFECTIVENESS OF NIVOLUMAB FOR THE ADJUVANT TREATMENT OF PATIENTS WITH MELANOMA WITH INVOLVEMENT OF LYMPH NODES OR METASTATIC DISEASE WHO HAVE UNDERGONE COMPLETE RESECTION: AN ANALYSIS FROM A SWISS HEALTHCARE SYSTEM PERSPECTIVE

Oniangue-Ndza, C., Strittmatter, G., Orsini, I., Teitsson, S., Augusto, M., Amadi, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.404
Date:
November, 2019
File:
PDF, 321 KB
2019
Conversion to is in progress
Conversion to is failed